Biotech Commentary – AFMD SRPT RLYP + Fed View + More. I start the audio giving some brief commentary on FOMC announcement today and explain why the FED has no credibility, and why it’s all noise except for tracking the…
Month: April 2016
Eteplirsen Adcomm Negative Vote Explained
Eteplirsen Adcomm Negative Vote Explained. In this video, I explain why we believe Eteplirsen Adcomm panel got their call wrong and why there is a chance (not a good one, but decent) that Janet Woodcock overrides everyone (within her power to…
Bullish Premium Videos Commentary Premium Articles Commentary Premium Videos Premium Articles Premium Videos
Our Official Prediction For eteplirsen Adcomm – Positive – Audio Explanation Why
Our Official Prediction For eteplirsen Adcomm – Positive – Audio Explanation Why. Points; 1.Adcomm does not approve or reject drugs, they recommend either approval or denial. This is not an adcomm for a standard route approval, but an accelerated route…
Stock Market And Biotech Commentary Thurs Apr 21
Stock Market And Biotech Commentary Thurs Apr 21. Explanation on how USA Treasury is keeping stock markets propped up via buying a few large cap companies and keeping ‘the game’ floating. Explanation on small cap biotech $CERU, and why you…
Market Outlook And Biotech Commentary Week April 18-22
Market Outlook And Biotech Commentary Week April 18-22. Very long audio here coming in just under 30 minutes, but also very important. Chinese Gold backed Yuan explained and potential issues. Brief talk on expected NO OIL CUT/FREEZE non deal. I’m…
Video Chart Reviews For Friday April 1th – More RLYP Drama – Explained
Video Chart Reviews For Friday April 1th – More RLYP Drama – Explained.. First I give a brief overview of the $SPY chart.. Afterwards, I discuss in detail the nonsense occurring in $RLYP — again. After hours we had an…
Bullish Premium Articles Bullish Premium Videos Commentary Premium Articles Commentary Premium Videos Premium Articles Premium Videos
Affimed’s Science Simplified – Part 1
Affimed’s Science Simplified – Part 1.. Please refer to http://stockmatusow.com/affimed-science-explained-technical-breakdown as I break down the technical terms and science of Affimed’s AFM 13’s action mechanism and safety profile. I explain in part 1 how it works in comparison to others, and reiterate why…
Audio: Relypsa Commentary – How I think it will play out + AFMD
Audio: Relypsa Commentary – How I think it will play out + AFMD.. In the below audio, I give my views on how I think $RLYP will play out, the various scenarios how it could play out both positive and…
Affimed Science Explained – Technical Breakdown
Danny has explained Affimed’s science below, which for some may be a bit complex. Tomorrow, I will look to break down the technical explanations in more simpler terms — this is a big reason many up and coming TRUE potential…
AFMD Differentiation Basic Explanation + ACAD and RLYP
AFMD Differentiation Basic Explanation + ACAD and RLYP.. Starter on AFMD and how it’s strongly differentiated from potential competitors in their space moving forward. The differentiation here is that AFMD has the only wholly owned antibody targeting the mutated…
